A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION

心脏基因表达的 A1-肾上腺素调节

基本信息

  • 批准号:
    3360227
  • 负责人:
  • 金额:
    $ 18.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-07-01 至 1994-06-30
  • 项目状态:
    已结题

项目摘要

This work is focused on the clinical problem of myocardial hypertrophy, specifically the molecular mechanisms which regulate this process. A new model system was developed to study hypertrophy, employing neonatal heart myocytes in serum-free culture. The novel observation was made that stimulation of the alpha 1-adrenergic receptor on these cells by the catecholamine norepinephrine induces cell enlargement or hypertrophy, without DNA synthesis. The alpha 1-adrenergic receptor is the first receptor shown to regulate cardiac myocyte hypertrophy. Recent work has shown that the alpha 1 receptor regulates mRNA expression during hypertrophy. In particular, alpha 1 stimulation induces two contractile protein iso-mRNAs characteristic of early cardiac development and pressure-load hypertrophy in vivo, skeletal alpha-actin iso-mRNA and B-myosin heavy chain iso-mRNA. This alpha 1 receptor effect is selective and is mediated at the level of iso-gene transcription. Thus, the critical question is the mechanism for induction of transcription by the alpha 1 receptor. The present experiments will test the hypothesis that the skeletal alpha- actin iso-gene and the B-myosin heavy chain iso-gene contain one or more alpha 1 response elements, i.e., DNA sequences required specifically for transcription of these genes in response to alpha 1-adrenergic stimulation. Two complementary experimental approaches for functional identification alpha 1 response elements are proposed: (1) transfection of hybrid genes in a transient assay system; and (2) DNase I hypersensitivity mapping. The necessary cloned genes are available to begin these experiments and preliminary studies provide evidence that the work is feasible. The long-range goal is to define the intracellular pathway from the alpha 1 receptor at the cell surface to gene transcription. The overall hypothesis is that receptor stimulation activates a pre-existing protein or proteins that binds to the alpha 1 response element in a transcriptional complex with RNA polymerase II. Identification of an alpha 1 response element or elements in the present work will provide the foundation for subsequent identification of the protein or proteins.
本研究主要针对心肌肥厚的临床问题,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL C SIMPSON其他文献

PAUL C SIMPSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL C SIMPSON', 18)}}的其他基金

ShEEP Request for Ultrasound Imaging System
ShEEP 请求超声成像系统
  • 批准号:
    9908741
  • 财政年份:
    2019
  • 资助金额:
    $ 18.17万
  • 项目类别:
Novel therapy for cardiotoxicity of cancer drugs
抗癌药物心脏毒性的新疗法
  • 批准号:
    8443184
  • 财政年份:
    2012
  • 资助金额:
    $ 18.17万
  • 项目类别:
Novel therapy for cardiotoxicity of cancer drugs
抗癌药物心脏毒性的新疗法
  • 批准号:
    8598801
  • 财政年份:
    2012
  • 资助金额:
    $ 18.17万
  • 项目类别:
Novel therapy for cardiotoxicity of cancer drugs
癌症药物心脏毒性的新疗法
  • 批准号:
    8760306
  • 财政年份:
    2012
  • 资助金额:
    $ 18.17万
  • 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
  • 批准号:
    6151319
  • 财政年份:
    1997
  • 资助金额:
    $ 18.17万
  • 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
  • 批准号:
    6351490
  • 财政年份:
    1997
  • 资助金额:
    $ 18.17万
  • 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
  • 批准号:
    2872927
  • 财政年份:
    1997
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-1 ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 ALPHA-1 肾上腺素调节
  • 批准号:
    2220319
  • 财政年份:
    1989
  • 资助金额:
    $ 18.17万
  • 项目类别:
A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
  • 批准号:
    3360228
  • 财政年份:
    1989
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-1 ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 ALPHA-1 肾上腺素调节
  • 批准号:
    6030586
  • 财政年份:
    1989
  • 资助金额:
    $ 18.17万
  • 项目类别:

相似海外基金

MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6110455
  • 财政年份:
    1999
  • 资助金额:
    $ 18.17万
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6273039
  • 财政年份:
    1998
  • 资助金额:
    $ 18.17万
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6242449
  • 财政年份:
    1997
  • 资助金额:
    $ 18.17万
  • 项目类别:
Central and renal alpha-adrenergic receptor with the development of salt-induced hypertension in Dahl-Iwai salt-sensitive rats.
中枢和肾脏 α-肾上腺素能受体与 Dahl-Iwai 盐敏感大鼠中盐诱导高血压的发展。
  • 批准号:
    03670461
  • 财政年份:
    1991
  • 资助金额:
    $ 18.17万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402355
  • 财政年份:
    1984
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402353
  • 财政年份:
    1984
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    2264148
  • 财政年份:
    1984
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402348
  • 财政年份:
    1984
  • 资助金额:
    $ 18.17万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402354
  • 财政年份:
    1984
  • 资助金额:
    $ 18.17万
  • 项目类别:
IDENTIFICATION AND FUNCTION OF ALPHA-ADRENERGIC RECEPTOR
α-肾上腺素能受体的鉴定和功能
  • 批准号:
    3079007
  • 财政年份:
    1983
  • 资助金额:
    $ 18.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了